和黄医药(00013)将于2026年欧洲肿瘤内科学会胃肠道肿瘤大会公布凡瑞格拉替尼用于治疗肝内胆管癌的关键性II期研究数据
Last Update:
25 6 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.